← Leaderboards
Dong-Woo Kang
Dana-Farber Cancer Inst
$412,448
Attributed
$412,448
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$412,448 · 2
By mechanism
R00$249,000 · 1
K99$163,448 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kai W Wucherpfennig$37,935,181
- David A Barbie$12,794,638
- Toni Choueiri$2,782,193
- Panagiotis Konstantinopoulos$4,290,380
- Matthew Gilbert Oser$2,847,213
Others in their field
Other Rising Stars on “Circulating Biomarkers”
- Theresa Nguyen · Chromologic, Llc$4,879,349
- Justin Lee Grodin · Ut Southwestern Medical Center$3,560,217
- David T. Miyamoto · Massachusetts General Hospital$3,300,055
- Jeffrey B Ware · University Of Pennsylvania$3,116,729
- Suna Onengut · University Of Virginia$3,014,326
- Rana Ramzi McKay · University Of California, San Diego$2,984,495
Research focus
Circulating BiomarkersAdaptive ImmunityAdjuvantAntibodiesAnti-Inflammatory AgentsAdvanced DiseaseAdverse EventAwardBiological MarkersBloodB-LymphocytesCancer ImmunotherapyCancer PatientCancer PrognosisCancer SurvivorshipCancer TherapyCardiopulmonaryCareer DevelopmentCd8-Positive T-LymphocytesCell-Mediated CytolysisCell ProliferationCellsChronicClinical Care